Skip to main content
Premium Trial:

Request an Annual Quote

Academia Slows Down Translational Research?

In Newsweek, Sharon Begley says that NIH has to make translational medicine even more of a priority, citing stumbling blocks to the effort such as "academic advancement." She writes that academia prizes securing grants and publishing in highly-rated journals, but that those top journals are not interested in treatments -- only more niche-ones are -- and thus progress slows down. Orac at Respectful Insolence says Begley missed a few key points. "Begley seems blissfully ignorant of two things: How journal rankings work and the fact that different scientific journals fill different niches," he writes.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.